EN
HI
Summary
As of 29 Aug, 2026, Fredun Pharmaceuticals stock price is ₹1476.6. During the trading session, the stock has moved between an intraday low of ₹1465.70 and an intraday high of ₹1509.80. Over the last 52 weeks, Fredun Pharmaceuticals has traded between ₹1400.00 and ₹1590.00.
The stock has recorded a trading volume of 10,875 shares, with a market capitalization of ₹16538070. Its Average Traded Price (ATP) is ₹1488.40, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹1476.60.
Fredun Pharmaceuticals has an upper circuit limit of ₹1624.20 and a lower circuit limit of ₹1329.00. The total value traded stands at ₹1.62 CR, and the delivery percentage for the day is 53.89%.
The stock is currently traded with a market lot size of 1. Fredun Pharmaceuticals also offers a dividend yield of 0.02%.
Fredun Pharmaceuticals share price chart
Fredun Pharmaceuticals Share Key Metrics
Volume
10875.00
Market Cap
2442.01 CR
LTQ@LTP
1@1476.60
ATP
1488.4
Var Margin
25.65 %
Circuit Range
1329-1624.2
Delivery %
53.89 %
Value
1.62 CR
ASM/GSM
No
Market Lot
1
Fredun Pharmaceuticals Fundamentals
P/E Ratio
55.74
P/B Ratio
8.33
Div. Yield
0.02
Sector P/E
69.1
Sector P/B
3.41
Sec. Div. Yield
0.51
Fredun Pharmaceuticals Resistance and Support
Pivot 1498.07
Resistance
First Resistance
1521.44
Second Resistance
1550.17
Third Resistance
1573.54
Support
First Support
1469.34
Second Support
1445.97
Third Support
1417.24
Fredun Pharmaceuticals Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Aug 28 2026 | 1500.1 | 1476.6 | -1.08% | 1509.8 | 1465.7 |
| Thu Aug 27 2026 | 1519.9 | 1492.69 | -0.11% | 1526.8 | 1474.69 |
| Wed Aug 26 2026 | 1465.5 | 1494.3 | 3.16% | 1536 | 1446.9 |
Fredun Pharmaceuticals Corporate Actions
| Date | Agenda |
|---|---|
| 2025-09-25 | Preferential Issue of shares & Others |
| 2026-08-05 | Quarterly Results |
| 2026-05-25 | Audited Results |
| 2026-02-09 | Quarterly Results |
| 2025-11-08 | Quarterly Results |
| 2025-07-30 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-04 | Quarterly Results |
| 2024-10-26 | Quarterly Results |
| 2024-10-03 | Others |
| 2024-07-29 | Quarterly Results |
Fredun Pharmaceuticals News
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Fredun Pharmaceuticals' monitoring agency report highlighted significant deviations in the use of preferential allotment proceeds, with Rs. 13.21 crore deployed for purposes not explicitly covered by the stated objects. The report also noted discrepancies in the reported unutilized funds.
Aug 14 2026 22:27:06
Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Fredun Pharmaceuticals has made the audio recording of its Q1 FY27 earnings conference call available. The call, held on August 13, 2026, discussed the un-audited financial results for the quarter ended June 30, 2026, and can be accessed via the company's website.
Aug 13 2026 16:47:00
Read More
Fredun Pharmaceuticals Management
| Name | Position |
|---|---|
| Daisy Dsouza | Non Executive Independent Director |
| Sonal Desai | Non Executive Independent Director |
Fredun Pharmaceuticals Similar Stocks
Ind-Swift Laboratories Ltd.
362.92
4.88 (1.36%)
Solara Active Pharma Sciences Ltd.
623.70
11.85 (1.94%)
Dishman Carbogen Amcis Ltd.
174.77
-2.45 (1.38%)
Hikal Ltd.
204.23
-0.40 (0.20%)
Beta Drugs Ltd.
2201.00
6.80 (0.31%)
Dr Agarwals Eye Hospital Ltd.
5245.50
69.00 (1.33%)
Panacea Biotec Ltd.
395.50
2.25 (0.57%)
Sai Parenteral's Ltd.
521.35
0.65 (0.12%)
Fredun Pharmaceuticals FAQs
The Buying Price of Fredun Pharmaceuticals share is 1476.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Fredun Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Fredun Pharmaceuticals, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Fredun Pharmaceuticals shares is 55.74. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Fredun Pharmaceuticals shares is 8.33. Useful to assess the stock's value relative to its book value.
To assess Fredun Pharmaceuticals’s valuation compare Sector P/E, P/B which are 69.1 & 3.41 with sector averages, along with growth rates and financial metrics.
The Market Cap of Fredun Pharmaceuticals is 2442.01 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Fredun Pharmaceuticals share price is 1590.00 & 1400.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Fredun Pharmaceuticals belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
